The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

VIDEO: Should AMTL be defined as a distinct diagnostic entity? w/ @jbond2019 of @UCDMedicine: http://ow.ly/Wwo150AwBFo

@ESHaematology @VJHemOnc #HemOnc #Leukemia #Leusm #ESHAL2020 @OncoAlert #Oncoalert

📅 Have you saved these dates? We've got 2 NEW #EHA25Virtual Thematic Days, planned this July:

The #YoungEHA Day is coming up on (Friday) July 24! Following that, the EHA Awards Day is on (Friday) July 31. 👉Stay tuned for more updates!

Should #interferon be the first choice treatment for myeloproliferative neoplasms in 2020? Some thoughts at the #EHA25virtual MPN SWG session #MPNSM
👇
https://eha.conference2web.com/#!resources/the-role-of-interferon-in-mpns-in-2020

Just 1 day to go before The #AML Sessions webinar!

We're looking forward to hearing from Naval Daver, Andew Wei, Marion Subklewe, and Amir Fathi!

Register here to watch
👉http://ow.ly/Vvtk50AxS45 👈

@ASCO @EHA_Hematology #AMLsm #AcuteMyeloidLeukemia #Leusm @OncoAlert

Load More

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

VIDEO: Should AMTL be defined as a distinct diagnostic entity? w/ @jbond2019 of @UCDMedicine: http://ow.ly/Wwo150AwBFo

@ESHaematology @VJHemOnc #HemOnc #Leukemia #Leusm #ESHAL2020 @OncoAlert #Oncoalert

📅 Have you saved these dates? We've got 2 NEW #EHA25Virtual Thematic Days, planned this July:

The #YoungEHA Day is coming up on (Friday) July 24! Following that, the EHA Awards Day is on (Friday) July 31. 👉Stay tuned for more updates!

Should #interferon be the first choice treatment for myeloproliferative neoplasms in 2020? Some thoughts at the #EHA25virtual MPN SWG session #MPNSM
👇
https://eha.conference2web.com/#!resources/the-role-of-interferon-in-mpns-in-2020

Just 1 day to go before The #AML Sessions webinar!

We're looking forward to hearing from Naval Daver, Andew Wei, Marion Subklewe, and Amir Fathi!

Register here to watch
👉http://ow.ly/Vvtk50AxS45 👈

@ASCO @EHA_Hematology #AMLsm #AcuteMyeloidLeukemia #Leusm @OncoAlert

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter